Legal & General Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-30,739
| Closed | -$570K | – | 3411 |
|
|
2023
Q3 | $570K | Buy |
30,739
+1,610
| +6% | +$29.8K | ﹤0.01% | 2382 |
|
|
2023
Q2 | $322K | Buy |
29,129
+12,497
| +75% | +$138K | ﹤0.01% | 2606 |
|
|
2023
Q1 | $223K | Buy |
16,632
+4,084
| +33% | +$54.8K | ﹤0.01% | 2553 |
|
|
2022
Q4 | $155K | Buy |
12,548
+2,400
| +24% | +$29.7K | ﹤0.01% | 2701 |
|
|
2022
Q3 | $142K | Buy |
10,148
+680
| +7% | +$9.52K | ﹤0.01% | 2727 |
|
|
2022
Q2 | $131K | Sell |
9,468
-1,366
| -13% | -$18.9K | ﹤0.01% | 2778 |
|
|
2022
Q1 | $176K | Hold |
10,834
| – | – | ﹤0.01% | 2712 |
|
|
2021
Q4 | $176K | Sell |
10,834
-298
| -3% | -$4.84K | ﹤0.01% | 2767 |
|
|
2021
Q3 | $165K | Sell |
11,132
-4,156
| -27% | -$61.6K | ﹤0.01% | 2741 |
|
|
2021
Q2 | $305K | Buy |
15,288
+339
| +2% | +$6.76K | ﹤0.01% | 2433 |
|
|
2021
Q1 | $345K | Sell |
14,949
-34
| -0.2% | -$785 | ﹤0.01% | 2361 |
|
|
2020
Q4 | $370K | Sell |
14,983
-42
| -0.3% | -$1.04K | ﹤0.01% | 2314 |
|
|
2020
Q3 | $622K | Sell |
15,025
-1,129
| -7% | -$46.7K | ﹤0.01% | 2153 |
|
|
2020
Q2 | $774K | Buy |
16,154
+2,143
| +15% | +$103K | ﹤0.01% | 2059 |
|
|
2020
Q1 | $882K | Sell |
14,011
-1,213
| -8% | -$76.4K | ﹤0.01% | 1887 |
|
|
2019
Q4 | $1.89M | Buy |
15,224
+1,005
| +7% | +$125K | ﹤0.01% | 1827 |
|
|
2019
Q3 | $943K | Buy |
14,219
+3,787
| +36% | +$251K | ﹤0.01% | 2007 |
|
|
2019
Q2 | $830K | Buy |
10,432
+935
| +10% | +$74.4K | ﹤0.01% | 2012 |
|
|
2019
Q1 | $1.06M | Buy |
9,497
+184
| +2% | +$20.6K | ﹤0.01% | 1949 |
|
|
2018
Q4 | $939K | Buy |
9,313
+464
| +5% | +$46.8K | ﹤0.01% | 1921 |
|
|
2018
Q3 | $1.12M | Buy |
8,849
+2,086
| +31% | +$264K | ﹤0.01% | 1922 |
|
|
2018
Q2 | $567K | Sell |
6,763
-2,430
| -26% | -$204K | ﹤0.01% | 2075 |
|
|
2018
Q1 | $565K | Buy |
9,193
+337
| +4% | +$20.7K | ﹤0.01% | 2087 |
|
|
2017
Q4 | $518K | Hold |
8,856
| – | – | ﹤0.01% | 2083 |
|
|
2017
Q3 | $514K | Buy |
8,856
+2,882
| +48% | +$167K | ﹤0.01% | 2088 |
|
|
2017
Q2 | $723K | Buy |
5,974
+561
| +10% | +$67.9K | ﹤0.01% | 1944 |
|
|
2017
Q1 | $612K | Buy |
5,413
+3,588
| +197% | +$406K | ﹤0.01% | 1977 |
|
|
2016
Q4 | $199K | Buy |
1,825
+629
| +53% | +$68.6K | ﹤0.01% | 2246 |
|
|
2016
Q3 | $196K | Hold |
1,196
| – | – | ﹤0.01% | 2030 |
|
|
2016
Q2 | $171K | Buy |
1,196
+52
| +5% | +$7.44K | ﹤0.01% | 1835 |
|
|
2016
Q1 | $147K | Buy |
1,144
+156
| +16% | +$20K | ﹤0.01% | 1845 |
|
|
2015
Q4 | $148K | Buy |
988
+236
| +31% | +$35.4K | ﹤0.01% | 1878 |
|
|
2015
Q3 | $125K | Buy |
752
+102
| +16% | +$17K | ﹤0.01% | 1911 |
|
|
2015
Q2 | $157K | Buy |
650
+194
| +43% | +$46.9K | ﹤0.01% | 1852 |
|
|
2015
Q1 | $129K | Buy |
+456
| New | +$129K | ﹤0.01% | 1878 |
|